Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 50 Sunscreen
- Manufacturer
- Allergan, Inc.
- Effective date
- 2013-04-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:27:58
Label at a glance#
ProductTOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 50 Sunscreen
Active ingredientHOMOSALATE, OCTINOXATE, OCTISALATE, ZINC OXIDE
Label structure9 sections
Dosage and administration
apply liberally 15 minutes before sun exposure reapply after 80 minutes of swimming or sweating, at least every 2 hours, or after towel drying to avoid lowering protection Sun Protection Measures UV exposure from the sun increases the risk of skin cancer, premature skin aging and other skin damage To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection me...
Contacts and useful links#
Websitewww.skinmedica.com
www.skinmedica.com
www.skinmedica.comLabel contents#
Full prescribing information#
Active ingredients
Homosalate 6.0%
Octinoxate 7.5%
Octisalate 5.0%
Zinc Oxide 10.0%
Purpose
Sunscreen
Sunscreen
Sunscreen
Sunscreen
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor if rash occurs
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
- apply liberally 15 minutes before sun exposure
- reapply after 80 minutes of swimming or sweating, at least every 2 hours, or after towel drying to avoid lowering protection
- Sun Protection Measures UV exposure from the sun increases the risk of skin cancer, premature skin aging and other skin damage To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including limiting time in the sun from 10 a m -2 p.m., and wearing protective clothing
- children under 6 months: Ask a doctor
Inactive ingredients
Water, Caprylic/Capric Triglyceride, Butyloctyl Salicylate, Styrene/Acrylates Copolymer, Niacinamide, Silica. Glyceryl Stearate. PEG-100 StearatB. Ceteaiyl Alcohol. Squalane, Polygonum Aviculare Extract Physalis Angulata Extract, Dunaliella Salina Extract. Ubiquinone, Glycerin. Camellia Sinensis Leaf Extract Melanin, Tocopheryl Acetate, Tocopherol, Hydroxyacetophenone. Batyl Alcohol. C12-15 Alkyl Benzoate, Butylene Glycol. Ceteareth-20. Polyhydroxystearic Acid, Isostearic Acid, Acrylates Copolymer, Xanthan Gum, Ethylhexylglycerin, Disodium EDTA. Caprylyl Glycol, Sorbic Acid, Phenoxyethanol
Other information
- protect the product in this container from excessive heat and direct sun
- store at room temperature 15°- 30°C (59°- 86°F)
Questions or comments
Principal Display Panel - Carton Label
TOTAL DEFENSE
+
REPAIR
Broad Spectrum SPF 50+ Sunscreen
Water Resistant (80 Minutes)
+ INFRARED PROTECTION
Net Wt. 6 x 1.0 Oz Travel
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0023-5501-01 | 2021-11-12 | C162847 | 48780-1 | c7ccaba7-20d9-fd44-e053-dadaa90aa01b | Total Defense Repair Broad Spectrum SPF 50 Sunscreen Drug Facts |
| 0023-5501-03 | 2021-11-12 | C162847 | 48780-1 | c7ccaba7-20d9-fd44-e053-dadaa90aa01b | Total Defense Repair Broad Spectrum SPF 50 Sunscreen Drug Facts |
| 0023-5501-25 | 2021-11-12 | C162847 | 48780-1 | c7ccaba7-20d9-fd44-e053-dadaa90aa01b | Total Defense Repair Broad Spectrum SPF 50 Sunscreen Drug Facts |
| 0023-5501-01 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-20d9-fd44-e053-dadaa90aa01b | Total Defense Repair Broad Spectrum SPF 50 Sunscreen Drug Facts |
| 0023-5501-03 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-20d9-fd44-e053-dadaa90aa01b | Total Defense Repair Broad Spectrum SPF 50 Sunscreen Drug Facts |
| 0023-5501-25 | 2021-07-23 | C162847 | 48780-1 | c7ccaba7-20d9-fd44-e053-dadaa90aa01b | Total Defense Repair Broad Spectrum SPF 50 Sunscreen Drug Facts |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Homosalate | ACTIVE INGREDIENT | V06SV4M95S | 1 | |
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| Homosalate | ACTIVE MOIETY | V06SV4M95S | 1 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| Zinc Oxide | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| .Alpha.-Tocopherol Acetate, D- | INACTIVE INGREDIENT | A7E6112E4N | 1 | |
| 2'-Hydroxyacetophenone | INACTIVE INGREDIENT | 3E533Z76W0 | 1 | |
| Batilol | INACTIVE INGREDIENT | 39YR661C4U | 1 | |
| Butylene Glycol | INACTIVE INGREDIENT | 3XUS85K0RA | 1 | |
| Butyloctyl Salicylate | INACTIVE INGREDIENT | 2EH13UN8D3 | 1 | |
| C12-15 Alkyl Benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| Cetostearyl Alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| Dunaliella Salina | INACTIVE INGREDIENT | F4O1DKI9A6 | 1 | |
| Edetate Disodium | INACTIVE INGREDIENT | 7FLD91C86K | 1 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Glyceryl Stearate SE | INACTIVE INGREDIENT | FCZ5MH785I | 1 | |
| Green Tea Leaf | INACTIVE INGREDIENT | W2ZU1RY8B0 | 1 | |
| Hydrated Silica | INACTIVE INGREDIENT | Y6O7T4G8P9 | 1 | |
| Isostearic Acid | INACTIVE INGREDIENT | X33R8U0062 | 1 | |
| Medium-Chain Triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| Melanin Synthetic (tyrosine, Peroxide) | INACTIVE INGREDIENT | O0CV1RMR44 | 1 | |
| Niacinamide | INACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| PEG-100 Stearate | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| Physalis Angulata | INACTIVE INGREDIENT | W4TKW9D5GG | 1 | |
| Polygonum Aviculare Top | INACTIVE INGREDIENT | ZCD6009IUF | 1 | |
| Polyhydroxystearic Acid (2300 Mw) | INACTIVE INGREDIENT | YXH47AOU0F | 1 | |
| Polyoxyl 20 Cetostearyl Ether | INACTIVE INGREDIENT | YRC528SWUY | 1 | |
| Sorbic Acid | INACTIVE INGREDIENT | X045WJ989B | 1 | |
| Squalene | INACTIVE INGREDIENT | 7QWM220FJH | 1 | |
| Styrene/Acrylamide Copolymer (MW 500000) | INACTIVE INGREDIENT | 5Z4DPO246A | 1 | |
| Tocopherol | INACTIVE INGREDIENT | R0ZB2556P8 | 1 | |
| Ubidecarenone | INACTIVE INGREDIENT | EJ27X76M46 | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Xanthan Gum | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- TOTAL DEFENSE REPAIR BROAD SPECTRUM SPF 50 Sunscreen
- Homosalate, Octinoxate, Octisalate and Zinc Oxide
- HOMOSALATE
- OCTINOXATE
- OCTISALATE
- ZINC OXIDE
- WATER
- MEDIUM-CHAIN TRIGLYCERIDES
- BUTYLOCTYL SALICYLATE
- STYRENE/ACRYLAMIDE COPOLYMER (MW 500000)
- NIACINAMIDE
- HYDRATED SILICA
- GLYCERYL STEARATE SE
- PEG-100 STEARATE
- CETOSTEARYL ALCOHOL
- SQUALENE
- PHENOXYETHANOL
- POLYOXYL 20 CETOSTEARYL ETHER
- POLYHYDROXYSTEARIC ACID (2300 MW)
- BATILOL
- 2'-HYDROXYACETOPHENONE
- GLYCERIN
- .ALPHA.-TOCOPHEROL ACETATE, D-
- PHYSALIS ANGULATA
- BUTYLENE GLYCOL
- ALKYL (C12-15) BENZOATE
- XANTHAN GUM
- EDETATE DISODIUM
- ETHYLHEXYLGLYCERIN
- ISOSTEARIC ACID
- GREEN TEA LEAF
- POLYGONUM AVICULARE TOP
- UBIDECARENONE
- MELANIN SYNTHETIC (TYROSINE, PEROXIDE)
- DUNALIELLA SALINA
- CAPRYLYL GLYCOL
- TOCOPHEROL
- SORBIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0023-5501 | 0023-5501-03, 0023-5501-01, 0023-5501-25 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | SPRAY / TOPICAL | 1 %w/w | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | LOTION / TOPICAL | 4 mg | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| Polyoxyl 20 Cetostearyl Ether | POLYOXYL 20 CETOSTEARYL ETHER | YRC528SWUY | SPRAY / TOPICAL | 2.42 %w/w | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | TABLET, EXTENDED RELEASE / ORAL | 800 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / NASAL | 100 mg/100ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / RECTAL | 2 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TRANSDERMAL | 8.12 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / OPHTHALMIC | 0.06 %w/v | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER / SUBLINGUAL | 2 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET / ORAL | 100 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, CHEWABLE / ORAL | 1 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | PASTE / ORAL | 1050 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SPRAY, METERED / NASAL | 4 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / AURICULAR (OTIC) | 0.05 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | GEL / OPHTHALMIC | 396 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / ORAL | 32400 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SYRUP / ORAL | 40 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRACARDIAC | 2 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TABLET, EXTENDED RELEASE / ORAL | 528 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / SOFT TISSUE | 1 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| Butylene Glycol | BUTYLENE GLYCOL | 3XUS85K0RA | SYSTEM / TOPICAL | 1400 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CAPSULE, EXTENDED RELEASE / ORAL | 9.43 mg | ||
| Glyceryl Stearate SE | GLYCERYL STEARATE SE | FCZ5MH785I | CREAM / TOPICAL | 4 %w/w | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | CREAM / TOPICAL | 14 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVENOUS | 10 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | CREAM / TOPICAL | 14 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | LIQUID / NASAL | 2 mg/1ml | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | CONCENTRATE / ORAL | 20 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SOLUTION / ORAL | 84 mg | ||
| Edetate Disodium | EDETATE DISODIUM | 7FLD91C86K | LIQUID / INTRAVENOUS | 0.03 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / VAGINAL | 227.9 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYRUP / ORAL | 16734 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| Sorbic Acid | SORBIC ACID | X045WJ989B | TABLET, CHEWABLE / ORAL | NA | ||
| Tocopherol | TOCOPHEROL | R0ZB2556P8 | INJECTION, EMULSION / INTRAVENOUS | 0.02 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TROCHE / ORAL | 948 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM, AUGMENTED / TOPICAL | 10 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.6 %w/w | ||
| Isostearic Acid | ISOSTEARIC ACID | X33R8U0062 | GEL / TOPICAL | 20 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 4fce45e1-22af-4fe9-ae90-6acf8d480051 | 54164461-0c04-433c-8675-3df8cd2ad048 | 2013-04-01 | Warnings | 54164461-0c04-433c-8675-3df8cd2ad048 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.